FDA Accountability Issues
Vinay expresses deep concern over the FDA's relationship with Biogen, particularly regarding the controversial Alzheimer's drug. He highlights a troubling pattern of regulatory capture, where the agency prioritizes the interests of pharmaceutical companies over public safety. This raises critical questions about the integrity of drug approval processes and the influence of a vocal minority on regulatory decisions.In this clip
From this podcast
EconTalk
Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Related Questions